leisure time -WSS

leisure time

author：fashion 2025-09-28 02:28:55 - browse：9

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： DeSantis can now import cheaper drugs. But will Biden get credit?

Wikipedia

WSS

JPM 2024: Nvidia claims we're in biological revolution. Are we?

U.K. Biobank has 500,000 peoples' genome sequences available

The SUPPORT Act is critical to fighting the opioid crisis

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Generative AI mines health records to identify patients’ social needs

DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

leisure time

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

Generative AI mines health records to identify patients’ social needs

Drug repurposing or repositioning? The language matters

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Supreme Court strikes down use of affirmative action

New Medicare drug pricing powers could soon be upended in court

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to do when lifesaving products contribute to climate change

Novavax promises a turnaround & Lilly roils the obesity market

How to pay for weight loss drugs and save Medicare

explore

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Pediatric cancer treatments threatened by a new FDA policy

Risky weight loss products often used by teens globally, per study

How I ended up pumping milk in a bathroom stall at JPM 2024

How I ended up pumping milk in a bathroom stall at JPM 2024

Diagnostic tests are hitting their mathematical limits

focus

hotspot

Wikipedia

knowledge